Nicole Martin, APRN
Adult Health · Southbury, CTNPI 1154092344
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 283 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,065, more than ten times the $13 reported in 2022. Among adult health clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 283 payments — averaging $18.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$987
- Lilly USA, LLC$792
- GSK$654
- Pfizer$463
- Exact Sciences$425
- AstraZeneca$319
- plus $2K from 17 others
What the payments were for
- Food & beverage$5,162100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 61 | $987 |
| Lilly USA, LLC | 39 | $792 |
| GSK | 36 | $654 |
| Pfizer | 31 | $463 |
| Exact Sciences | 20 | $425 |
| AstraZeneca | 15 | $319 |
| Novo Nordisk | 14 | $297 |
| Boehringer Ingelheim | 16 | $287 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 16 | $257 |
| Sumitomo Pharma America, Inc. | 10 | $215 |
| Idorsia Pharmaceuticals US Inc | 5 | $79 |
| E.r. Squibb & Sons, L.L.C. | 2 | $53 |
| Lundbeck LLC | 3 | $51 |
| Astellas Pharma US Inc | 2 | $50 |
| Eisai Inc. | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 3 | $34 |
| Currax Pharmaceuticals LLC | 2 | $34 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $24 |
| Medtronic | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Intra-sana Laboratories | 1 | $18 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
How this compares
$5,162 in reported general payments places this provider in the 90th percentile of 418 adult health providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 26 | $31,122 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 20 | $15,475 |
| FarxigaDapagliflozin Propanediol | 11 | $11,423 |
| SymbicortBudesonide/Formoterol Fumarate | 28 | $7,086 |
| QuviviqDaridorexant Hcl | 13 | $6,453 |
| Dexlansoprazole DrDexlansoprazole | 12 | $1,907 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 52 | $1,053 |
| Losartan Potassium | 104 | $813 |
| Atorvastatin Calcium | 115 | $791 |
| Amlodipine Besylate | 81 | $463 |
| Gabapentin | 48 | $462 |
| Levothyroxine Sodium | 53 | $408 |
| Fluticasone Propionate | 36 | $387 |
| Pantoprazole Sodium | 26 | $360 |
| Lisinopril | 54 | $334 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $463 | $31,12226 claims |
| AstraZenecaFarxiga, Symbicort | $319 | $18,50839 claims |
| GSKTrelegy Ellipta | $654 | $15,47520 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $79 | $6,45313 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $15 | $40853 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 418 adult health providers in Connecticut.
Other adult health in Southbury
- Leah EhleManchester$418K
- Laura MulkaWethersfield$306K
- Gretchen MichaelsonSouth Windsor$169K
- Kimberly RyanWethersfield$74K
- Kathryn JackMeriden$67K
- Lynn RapsilberTorrington$52K
- Genice NelsonFarmington$36K
- Andrea LauterNew London$32K
- Megan CarlucciManchester$28K
- Kellie HaleNew Haven$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.